pharma · T Cell Lymphoma · Diabetes Mellitus · CRSP
S.A
S.A.
S.A is a pharma organization headquartered in San Lorenzo, EU. It trades on NYSE under ticker CRSP. Primary therapeutic focus areas include T Cell Lymphoma, Diabetes Mellitus, Beta-Thalassemia, Sickle Cell Disease, B-cel
San Lorenzo, EU HQ
2011 Founded
50 Employees
Public company Type
CRSP · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Lorenzo, EU
- Founded
- 2011
- Employees
- 50
- Programs
- 14
- Drugs
- 8
- Patents
- 65
CTX110
Phase 2 · mab · B-cell Malignancy
CTX110 for B-cell Malignancy is a Phase 2 program (mab) at S.A. with 1 ClinicalTrials.gov record(s).
Internal code CRSP-ONC-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.A.
- Phase
- Phase 2
- Modality
- mab
- Indication
- B-cell Malignancy
- Status
- terminated
- Trials
- 1